EMBL-EBI | Chemical Biology Resources | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C19H21N3O |
| Net Charge | 0 |
| Average Mass | 307.397 |
| Monoisotopic Mass | 307.16846 |
| SMILES | Cc1ccc(-c2nc3ccc(C)cn3c2CC(=O)N(C)C)cc1 |
| InChI | InChI=1S/C19H21N3O/c1-13-5-8-15(9-6-13)19-16(11-18(23)21(3)4)22-12-14(2)7-10-17(22)20-19/h5-10,12H,11H2,1-4H3 |
| InChIKey | ZAFYATHCZYHLPB-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Roles: | anti-obesity agent Any substance which is used to reduce or control weight. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. GABA agonist A drug that binds to and activates γ-aminobutyric acid receptors. |
| Applications: | antidepressant Antidepressants are mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. antipsychotic agent Antipsychotic drugs are agents that control agitated psychotic behaviour, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. sedative A central nervous system depressant used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. antiparkinson drug A drug used in the treatment of Parkinson's disease. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. central nervous system depressant A loosely defined group of drugs that tend to reduce the activity of the central nervous system. GABA agonist A drug that binds to and activates γ-aminobutyric acid receptors. anxiolytic drug Anxiolytic drugs are agents that alleviate anxiety, tension, and anxiety disorders, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| zolpidem (CHEBI:10125) has role analgesic (CHEBI:35480) |
| zolpidem (CHEBI:10125) has role anti-obesity agent (CHEBI:74518) |
| zolpidem (CHEBI:10125) has role antidepressant (CHEBI:35469) |
| zolpidem (CHEBI:10125) has role antineoplastic agent (CHEBI:35610) |
| zolpidem (CHEBI:10125) has role antiparkinson drug (CHEBI:48407) |
| zolpidem (CHEBI:10125) has role antipsychotic agent (CHEBI:35476) |
| zolpidem (CHEBI:10125) has role anxiolytic drug (CHEBI:35474) |
| zolpidem (CHEBI:10125) has role central nervous system depressant (CHEBI:35488) |
| zolpidem (CHEBI:10125) has role GABA agonist (CHEBI:51373) |
| zolpidem (CHEBI:10125) has role sedative (CHEBI:35717) |
| zolpidem (CHEBI:10125) is a imidazopyridine (CHEBI:46908) |
| Incoming Relation(s) |
| zolpidem tartrate (CHEBI:10126) has part zolpidem (CHEBI:10125) |
| IUPAC Name |
|---|
| N,N-dimethyl-2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetamide |
| INNs | Source |
|---|---|
| zolpidem | KEGG DRUG |
| zolpidemum | DrugBank |
| Synonyms | Source |
|---|---|
| N,N,6-Trimethyl-2-(4-methylphenyl)imidazo(1,2-a)pyridine-3-acetamide | ChemIDplus |
| Sanval | ChEMBL |
| Zolpidem civ | ChEMBL |
| Registry Numbers | Sources |
|---|---|
| Beilstein:4355785 | Beilstein |
| CAS:82626-48-0 | ChemIDplus |
| CAS:82626-48-0 | KEGG DRUG |
| CAS:82626-48-0 | NIST Chemistry WebBook |
| CAS:82626-48-0 | KEGG COMPOUND |
| CAS:82626-48-0 | DrugBank |
| Citations |
|---|